PGRMC1 and colonic neoplasm: Recent studies by Kabe et al. [72] have identified certain naturally occurring compounds (e.g., glycyrrhizin) that specifically bind to heme-dimerized PGRMC1 and interfere with the interaction of the PGRMC1 dimer with an EGF receptor, with functional consequences in terms of chemoresistance in colon cancer cells.